Navigation Links
'Virus chip' detects new virus in prostate tumors

UCSF and Cleveland Clinic scientists have discovered a new virus in human prostate tumors. The type of virus, closely related to viruses typically found in mice, has never been detected in humans. The virus's link to human disease is still unclear, and more study is needed to determine the relationship between the virus and cancer, if any, the scientists say.

The discovery was made with the same DNA-hunting "virus chip" used to confirm the identity of the SARS virus three years ago.

While the genetics of prostate cancer are complex, one of the first genes implicated in the disease was RNASEL, a gene that serves as an important defense against viruses. Given the anti-viral role of this gene, some scientists have speculated that a virus could be involved in some types of prostate cancers in men with mutated RNASEL genes.

In the new study, the researchers discovered the novel virus far more often in human prostate tumors with two copies of the RNASEL gene mutation than in those with at least one normal copy.

"This is a virus that has never been seen in humans before," said Eric Klein, MD, a collaborator in the research and head of urologic oncology at the Glickman Urologic Institute of Cleveland Clinic. "This is consistent with previous epidemiologic and genetic research that has suggested that prostate cancer may result from chronic inflammation, perhaps as a response to infection."

"The power of the virus chip resides in its ability to simultaneously screen for all viruses, without preconceptions or bias," said Joe DeRisi, PhD, a Howard Hughes Medical Institute (HHMI) investigator at UCSF who developed the chip with colleagues in his lab. "In the case of these prostate tissues, no one would have suspected a virus of this class." DeRisi is a UCSF associate professor of biochemistry and co-leader of the study with Don Ganem, MD, also an HHMI investigator at UCSF and a professor of microbiology and immunology.

Klein re
'"/>

Source:University of California - San Francisco


Page: 1 2 3

Related biology news :

1. Cardiologists living chip changes science of disease monitoring
2. MIT designs portable lab on a chip
3. Novel technology detects human DNA mutations
4. Robot-based system developed at Carnegie Mellon detects life in Chiles Atacama desert
5. New technique rapidly detects illness-causing bacteria
6. Olfactory system detects pheromones that control reproduction
7. Sports cheats beware -- new test detects previously undetectable drug
8. Fast test for low blood flow in dogs detects early heart trouble
9. Newly identified biomarker detects and regulates spread of brain tumors
10. New sensor detects gaseous chemical weapon surrogates in 45 seconds
11. A new portable biosensor detects traces of contaminants in food more quickly and cheaply
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Virus chip detects new virus prostate tumors

(Date:4/20/2015)... -- Huntington Memorial Hospital is the first facility in ... wireless monitoring sensor to manage heart failure (HF). The ... heart failure monitoring device that has been proven to ... manage heart failure. The CardioMEMS HF System ... artery (PA) during a non-surgical procedure to directly measure ...
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... nominated for the 2015 New York Design Awards under ... Design100, New York City Design Awards are part of ... on over 2,500 ratings from the marketplace, industry and ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
... Biology, researchers report using DNA from tissues samples collected in 1955 ... ( Orcinus orca ). In 1955, a pod ... a skeleton was saved in a museum in Wellington. Photographs were ... form of killer whale, characterized by a very small white eye-patch ...
... A decade-long JDRF-funded study led by the Institute ... providing a deeper understanding of the link between autoantibodies ... highlighting the importance of pre-diabetes research into possible preventions ... Autoantibodies and Risk of Progression to Diabetes in Children," ...
... 19, 2013  New York College of Health Professions announces the ... Office for detecting biometric changes through smart phones, apps and ... or killed. This patent is part of an ... College of Health Professions. Lisa Pamintuan , ...
Cached Biology News:New data on islet autoantibodies in young children defines early type 1 diabetes development 2New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 2New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 3New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 4
(Date:5/6/2015)... , May 6, 2015  Endo International plc (NASDAQ: ... De Silva , President and CEO, will present a corporate ... New York City on Wednesday, May 20, 2015 ... and audio archive for the event will be available on ... Relations, and then the link to the event. Participants should ...
(Date:5/6/2015)... 6, 2015  Oxis Biotech, Inc. (OXIS), a wholly ... announced today that Cassian Yee , M.D., Professor, ... at the University of Texas MD Anderson Cancer Center ... Professor, Department of Immunology, Division of Cancer Medicine, and ... Research at the University of Texas MD Anderson Cancer ...
(Date:5/6/2015)... The Remedy Group , the premier ... specialty pharmacy industry, will be exhibiting, presenting, and is ... Summit. The Summit will be held May 4-8, 2015 ... the largest annual gathering for the specialty pharmacy industry. ... providers, pharma/biotech manufacturers, and payers, to learn more about ...
(Date:5/5/2015)...  23andMe, Inc., the leading personal genetics company, today ... in collaboration with Pfizer Inc. The companies aim ... commonly known as lupus, into the study to help ... also in collaboration with the Lupus Research Institute, and ... Approximately 1.5 million people in the U.S. suffer ...
Breaking Biology Technology:Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3The Remedy Group presenting at the 2015 Armada Specialty Pharmacy Summit: The Pitfalls to Growth and Maintaining the Patient Experience 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 3
... populations with regard to risk associated in the development of ... osteoporosis or cardiovascular disease, - North American ... in response to nutritional products (nutrigenomics),- North ... Feb. 28 Interleukin Genetics,Inc. (Amex: ILI ) reported today ...
... the following Webcast:, What: Transgenomic Inc. Fourth ... Conference Call, When: Thursday, February 28, ... How: Live over the Internet -- Simply ... address above., To access the call via telephone, ...
... SAN DIEGO, Feb. 28 Anadys Pharmaceuticals,Inc. (Nasdaq: ... in a,Phase I study of ANA773, the company,s oral ... first-in-human trial is a safety,and tolerability study designed to ... as to select the dose and,schedule for Phase II ...
Cached Biology Technology:Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 2Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 3Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 4Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 5Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 2Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 3Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 4